PCMA told Specialty Pharmacy Times that DIR fees are not harmful. “They don’t harm the health industry in any way. They only help it,” PCMA President and CEO Mark Merritt told SPT. “It reduces costs for consumers and for Medicare. The reason people attack DIR is they sign a contract to pay for it, and then they don’t want to hold up their end of the bargain. The reality is payers are going to demand discounts, concession, and rebates to reduce costs to pass those savings along to consumers.”